Table 4.
Clinical laboratory analytes of Pacific Island patients with HCC
| PI-born (n = 92) | US-born (n = 153) | P value | Unadjusted OR, 95%CI | |
|---|---|---|---|---|
| Albumin (mg/dL) | 3.24 ( 0.77) | 3.54 ( 0.65) | P = 0.003 | |
| Bilirubin (mg/dL) | 2.42 ( 4.30) | 2.14 ( 4.11) | P = 0.62 | |
| Creatinine (mg/dL) | 1.26 ( 0.97) | 1.09 ( 0.71) | P = 0.14 | |
| Platelets (x103/μl) | 178 ( 101) | 179 ( 90) | P = 0.98 | |
| INR | 1.24 ( 0.28) | 1.18 ( 0.22) | P = 0.06 | |
| Median AFP (ng/dL | 25.9 | 34.8 | P = 0.90 | |
| Normal AFP (< 20 ng/dL) | 41 (45%) | 56 (38%) | 1.33 (0.79–2.26) | |
| Mean MELD score | 12 ( 5) | 11 ( 5) | P = 0.09 |
HCC: Hepatocellular carcinoma; PI-born: Pacific Island-born; NASH: nonalcoholic steatohepatitis; NAFLD: nonalcoholic fatty liver disease; BCLC: barcelona clinic liver cancer; INR: international normalized ratio; AFP: alpha-fetoprotein; MELD: model for end-stage liver disease.